| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/18/2005 | US20050181997 For preservation of hematopoietic progenitor cells; useful for isolating rare, primitive progenitor cells; nontoxic |
| 08/18/2005 | US20050181996 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 08/18/2005 | US20050181985 Coupling proteins to a modified polysaccharide |
| 08/18/2005 | US20050181507 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 08/18/2005 | US20050181505 Cosmetic repair using cartilage producing cells and medical implants coated therewith |
| 08/18/2005 | US20050181504 Using plug flow bioreactor system which mimics bone marrow microenvironment for propagation and maintenance of stromal cells |
| 08/18/2005 | US20050181502 Multipotent adult stem cells and methods for isolation |
| 08/18/2005 | US20050181381 Using presence of bone marrow stem cells as tool in predicting cell proliferative disorders associated with chronic inflammation |
| 08/18/2005 | US20050181065 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 08/18/2005 | US20050181064 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith |
| 08/18/2005 | US20050181051 Contains Cefixime Trihydrate, Cloxacillin Sodium (sustained release and immediate release form), Lactobacillus sporogenes spores |
| 08/18/2005 | US20050181042 Composition for oral or rectal administration |
| 08/18/2005 | US20050181016 Decullularized extracellular matrix of conditioned body tissues and uses thereof |
| 08/18/2005 | US20050180992 Fabricating wet spun or electrospun fibers using nanometer scale liquid crystalline viral particle suspensions where particle composition and function can be modified genetically to include binding or nucleating conjugate moieties while maintaining fibrous structure end product |
| 08/18/2005 | US20050180964 Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species |
| 08/18/2005 | US20050180963 Probiotic propionibacterium |
| 08/18/2005 | US20050180962 treating a non-alcoholic fatty liver disease; inactivated probiotic bacteria; and a pharmaceutically acceptable excipient; gastrointestinal inflammation; allergic asthma |
| 08/18/2005 | US20050180961 Probiotics and oral tolerance |
| 08/18/2005 | US20050180960 producer cell (encapsulated in a matrix containing immunostimulating alginates) expresses a molecule that is an inhibitor of the growth of a CNS tumor |
| 08/18/2005 | US20050180958 Using plug flow bioreactor system which mimics bone marrow microenvironment for propagation and maintenance of stromal cells; transplanting undifferentiated hemopoietic stem cells into a recipient |
| 08/18/2005 | US20050180957 composition comprising a fibrinogen, a fibrinolysis inhibitor, an angiogenic growth factor, one or more encapsulated cells, a thrombin and a divalent salt; stimulating vascularization at a transplant site |
| 08/18/2005 | US20050180956 SSAO enzyme substrates for vasorelaxation, and methods of use thereof |
| 08/18/2005 | US20050180955 gene therapy; delivering recombinant adeno-associated virus virions to the brain; pumping; transgene encodes an aromatic amino acid decarboxylase |
| 08/18/2005 | US20050180951 Fusion of autologous dendrtic cells with cancer cells that have the same class I MHC haplotype as said patient; and interleukin-12 |
| 08/18/2005 | DE19928210B4 Neuronales Zellmaterial und Verfahren zu dessen Herstellung Neural cell material and process for its preparation |
| 08/18/2005 | DE102004003801A1 Recovering melanin from plant materials, for use e.g. in cancer treatment or as semiconductor, by extracting with sodium hydroxide solution, acidifying extract and purifying precipitate |
| 08/18/2005 | DE102004003572A1 Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens Monoparamunity based on attenuated rabbit myxomaviruses |
| 08/18/2005 | CA2556161A1 Heparan-sulfate proteoglycan degrading enzymes for promotion of nerve regeneration |
| 08/18/2005 | CA2555083A1 Genes associated with canine osteoarthritis and related methods and compositions |
| 08/18/2005 | CA2554352A1 Compositions containing internally activated antioxidant |
| 08/18/2005 | CA2547843A1 Composition comprising polymeric material and uses thereof |
| 08/17/2005 | EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease |
| 08/17/2005 | EP1563847A1 Agent eleveting dendritic cell precursor level in blood |
| 08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
| 08/17/2005 | EP1563061A1 Cultivation of hair inductive cells |
| 08/17/2005 | EP1563059A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 08/17/2005 | EP1563058A1 Hemangioblast progenitor cells |
| 08/17/2005 | EP1562977A2 Active specific immunotherapy of cancer metastasis |
| 08/17/2005 | EP1562636A2 Mesenchymal stem cells and methods of use thereof |
| 08/17/2005 | EP1436380B1 Composition comprising a lactobacillus strain and uses thereof |
| 08/17/2005 | EP1248643B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 08/17/2005 | EP1161250B1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 08/17/2005 | EP1100878B8 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 08/17/2005 | EP1011710B1 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 08/17/2005 | EP0939804B1 NEUTROKINE alpha |
| 08/17/2005 | EP0784633B1 Process for purifying factor viii |
| 08/17/2005 | CN1656231A Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 08/17/2005 | CN1656216A Tolerogenic antigen-presenting cells |
| 08/17/2005 | CN1656215A Process for producing cytotoxic lymphocyte |
| 08/17/2005 | CN1655827A Novel use of adenoviruses and nucleic acids coding therefor |
| 08/17/2005 | CN1655810A Composition for treating or preventing hyperuricemia |
| 08/17/2005 | CN1655804A Method and composition for treating cardiovascular diseases by employing neuroregulation protein |
| 08/17/2005 | CN1655803A Methods of improving central nervous system functioning |
| 08/17/2005 | CN1655802A Bioadhesive directed somatic cell therapy |
| 08/17/2005 | CN1655798A Mixed-cell gene therapy |
| 08/17/2005 | CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 08/17/2005 | CN1655692A Alertness bar |
| 08/17/2005 | CN1655671A Animal model for toxicology and dose prediction |
| 08/17/2005 | CN1654477A Process for preparing transfer factor-heating method |
| 08/17/2005 | CN1654072A Immunoglobulin for dog intravenous injection, its preparing method and the formulation thereof |
| 08/17/2005 | CN1654042A Method for preparing natural organic silk worm protein for improving insulin excretion in diabetes patients |
| 08/17/2005 | CN1214813C Vulnerary for treating fracture |
| 08/17/2005 | CN1214809C Drip pills for curing aphtha and its preparing method |
| 08/17/2005 | CN1214808C Medicine for treating bone fracture |
| 08/17/2005 | CN1214804C Chinese medicine for treating face acne |
| 08/17/2005 | CN1214803C Chinese herbal medicine for treating No.5 diseaze of livestock and its usage |
| 08/17/2005 | CN1214802C Capsule for curing acne and its preparation process |
| 08/17/2005 | CN1214801C Face nursing and beautifying oral liquid |
| 08/17/2005 | CN1214799C Medicine for treating sciatic nerve diseases |
| 08/17/2005 | CN1214798C Nocar ointment for treating herpes simplex and herpes zoster |
| 08/17/2005 | CN1214797C Medicine for treating piles |
| 08/17/2005 | CN1214781C Hybrid matrices and hybrid matrix mixtures |
| 08/17/2005 | CN1214780C Cosmetic composition containing neuropeptide Y receptor antagonist |
| 08/16/2005 | US6929941 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 08/16/2005 | US6929806 Agents for improving lipid metabolism and reducing high blood pressure |
| 08/16/2005 | US6929798 Compositions and methods for treatment of microbial infections |
| 08/16/2005 | US6929793 Nutritional composition for treating an immune condition |
| 08/16/2005 | CA2224257C Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 08/11/2005 | WO2005073365A1 Method of treating cells for transplantation, cell suspension, prosthesis for transplantation and method of treating injured site |
| 08/11/2005 | WO2005073354A1 Solvent extraction of lipids such as essential fatty acids |
| 08/11/2005 | WO2005072764A2 Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
| 08/11/2005 | WO2005072754A1 Apicomlex vaccine strains of a family of sarcocystidae |
| 08/11/2005 | WO2005072753A1 Composition comprising platelet-rich plasma |
| 08/11/2005 | WO2005072718A1 Pharmaceutical compositions containing fermented whey |
| 08/11/2005 | WO2005072712A2 Antimicrobial composition |
| 08/11/2005 | WO2005072528A1 Anticancer glycoside compounds |
| 08/11/2005 | WO2005072477A2 Method for the separation of phospholipids from phospholipid-containing materials |
| 08/11/2005 | WO2005062791A3 Utilization of stem cell and fibroblast combined products and nutrients in topical compositions |
| 08/11/2005 | WO2005059119A3 Differentiated cells |
| 08/11/2005 | WO2005049647A3 Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens |
| 08/11/2005 | WO2005046579A3 Defined dose therapeutic phage |
| 08/11/2005 | WO2004082518A3 Method and compositions for improving animal health |
| 08/11/2005 | WO2004030626A3 In vitro culture of tissue structures |
| 08/11/2005 | WO2004009766A3 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 08/11/2005 | US20050177118 Inplantable device; wound healing agents for bones, soft tissure; polyelectrolyte complex; three-dimensional polymer network |
| 08/11/2005 | US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents |
| 08/11/2005 | US20050176672 Use of cationic lipids to generate anti-tumor immunity |
| 08/11/2005 | US20050176639 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 08/11/2005 | US20050176143 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 08/11/2005 | US20050176142 Mammalian megakaryocyte progenitor cell |